Argentina Leads Bayer's Clinical Studies in Latin America
Argentina is at the forefront of Bayer's clinical studies in Latin America, conducting six out of ten research projects in the region.
'Rehabilitation is decisive and cannot be sidelined in studies with polylaminin,' says doctor
A Brazilian doctor emphasizes the importance of prioritizing rehabilitation in the clinical studies of polylaminin, a substance being tested for acute spinal cord injury treatment.
Race for polylaminin outside clinical studies raises alarm about application risks
There has been a surge of over 5,000 people seeking polylaminin from Cristália and the courts, raising concerns among neurosurgeons about the substance's safety due to unverified efficacy.
Do mystical experiences with psychedelics really bring benefits for mental health?
The article discusses the potential mental health benefits of mystical experiences induced by psychedelics like psilocybin and LSD, supported by clinical studies suggesting these experiences can improve conditions such as depression and anxiety.
The cardiovascular risk of women starts before pregnancy and skyrockets after menopause
The article highlights that cardiovascular disease poses a significant threat to women, starting before pregnancy and increasing dramatically after menopause, yet remains underdiagnosed and underrepresented in clinical studies.